Dual Incretin Agonist 30mg — Verification Report
From S1Research · Lot PX010126S1 · Tested January 2026
VialTalk
Dual Incretin Agonist 30mg
S1Research
Score
92.7
Grade
A
Excellent
Cap color: Unresolved(not recorded; the report and the submitter did not confirm it)
Lot PX010126S1
Tested January 2026
Report ID
7a164f5e
Test
Method
Result
Status
PurityFull credit
HPLC
99.94%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentFull credit
Gravimetric vs label claim · tested weight disclosed and verified
30 mg labeled · 36.38 mg tested
Full credit
EndotoxinNot submitted
Not tested
Not tested
Not submitted
Heavy metalsNot submitted
Not tested
Not tested
Not submitted
SterilityNot submitted
Not tested
Not tested
Not submitted
Batch conformityNot submitted
Not tested
Not tested
Not submitted
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/s1research/coas/7a164f5e-2c22-4d3d-9c37-54749077daca